Fibersol itself is low in sugar
While promising, more human studies are needed to confirm its effects
Open original source PubChem identity record PubChem copper tripeptide-1 record PUBCHEM.NCBI.NLM.NIH.GOV Review the original source for its methods, study population or model, endpoints, limitations, and reported findings
Still, eat regular meals, avoid crash diets, and report symptoms like sweating, tremors, confusion, or fainting
Semaglutide GLP-1 S, on the other hand, is studied within a much broader and more validated use case, with trial data reporting average body weight reductions exceeding 14% over 68 weeks a proof point that has made GLP-1 receptor agonists a far more established research category for metabolic and weight-related studies than growth hormone fragment peptides like AOD-9604
B.CoronE.DrouardA.NguyenJ